Members' Business Motion · S1M-01676 · Session 1
Treatment for Alzheimer's Sufferers
The motion
That the Parliament notes that around 23,000 people in Scotland suffer from mild to moderate Alzheimer’s Disease; further notes the advice given by the National Institute for Clinical Excellence that the Alzheimer’s treatments Aricept, Exelon, and Riminyl be made available to sufferers of mild to moderate Alzheimer’s Disease by health authorities in England and Wales, and believes that the Scottish Executive should recommend immediately to health boards in Scotland that these treatments be made available to appropriate patients.
Signatures by party
25 MSPs besides the lodger · 3 from other partiesSNP 22LD 1Green 1SSP 1
Party on the day each MSP signed. Signing a motion is voluntary and not whipped. Who signs whose motions
Vote
No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.
Supporters
25 MSPsSNP 22 LD 1 Green 1 SSP 1
Show all 25 supporters by party
SNP 22
- Colin Campbell
- Dorothy-Grace Elder
- Fergus Ewing
- Margaret Ewing
- Linda Fabiani
- Kenneth Gibson
- Christine Grahame
- Duncan Hamilton
- Fiona Hyslop
- Adam Ingram
- Kenny MacAskill
- Tricia Marwick
- Michael Matheson
- Fiona McLeod
- Alex Neil
- Lloyd Quinan
- Shona Robison
- Michael Russell
- Alex Salmond
- Kay Ullrich
- Sandra White
- Andrew Wilson
LD 1
Green 1
SSP 1
Party shown is each supporter’s party when the motion was published.
In the Official Report
No contribution in the Official Report cites S1M-01676 by reference.